{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:20:24Z","timestamp":1795072824237,"version":"4.10.2"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA237384"],"award-info":[{"award-number":["R37CA237384"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP200173"],"award-info":[{"award-number":["RP200173"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["75N91019D00021-P00001-759102000002-1"],"award-info":[{"award-number":["75N91019D00021-P00001-759102000002-1"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA249924-02"],"award-info":[{"award-number":["CA249924-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA277161-01A1"],"award-info":[{"award-number":["CA277161-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA27651"],"award-info":[{"award-number":["R01CA27651"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL154720"],"award-info":[{"award-number":["R01HL154720"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL133900"],"award-info":[{"award-number":["R01HL133900"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK122796"],"award-info":[{"award-number":["R01DK122796"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210045"],"award-info":[{"award-number":["RP210045"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180734"],"award-info":[{"award-number":["RP180734"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Immunoprevention is an emerging consideration for solid tumors, including pancreatic ductal adenocarcinoma (PDAC). We and others have shown that Kras mutations in genetic models of spontaneous pancreatic intraepithelial neoplasia (PanIN), which is a precursor to PDAC, results in CD73 expression in the neoplastic epithelium and some populations of infiltrating immune cells, including macrophages and CD8 T cells. CD73 is an ecto-enzyme that converts extracellular adenosine monophosphate to adenosine, a critical immune inhibitory molecule in PDAC. We hypothesized inhibition of CD73 would reduce the incidence of PanIN formation and alter the immune microenvironment. To test our hypothesis, we used the KrasG12D; PdxCre1 (KC) genetically engineered mouse model and tested the utility of AB-680, a small molecule inhibitor targeting CD73, to inhibit PanIN progression. AB-680, or vehicle control, was administered using oral gavage delivery 3 days\/week at 10 mg\/kg, beginning when the mice were 2 months old and lasting 3 months. We euthanized the mice at 5 months old. In the KC model, we quantified significantly less pancreatitis, early and advanced PanIN, and quantified a significant increase in M1 macrophages in AB-680-treated mice. Single-cell RNA sequencing (scRNA-seq) of pancreata of AB-680-treated mice revealed increased infiltration of CD4+ T cells, CD8+ T cells, and mature B cells. The scRNA-seq analysis showed that CD73 inhibition reduced M2 macrophages, acinar, and PanIN cell populations. CD73 inhibition enhanced immune surveillance and expanded unique clonotypes of TCR and BCR, indicating that inhibition of CD73 augments adaptive immunity early in the neoplastic microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>Previous studies found PanIN lesions in healthy pancreata. Not all progress to PDAC, suggesting a window for enhanced antitumor immunity through immunoprevention therapy. CD73 inhibition in our study prevents PanIN progression, reduces immune-suppressive macrophages and expands TCR and BCR unique clonotypes, highlighting an encouraging therapeutic avenue for high-risk individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-24-0200","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T02:17:18Z","timestamp":1722824238000},"page":"457-470","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia"],"prefix":"10.1158","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-4431","authenticated-orcid":false,"given":"Lincoln N.","family":"Strickland","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-9338","authenticated-orcid":false,"given":"Wendao","family":"Liu","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas. 2"},{"name":"Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-3004","authenticated-orcid":false,"given":"Usama","family":"Hussein","sequence":"additional","affiliation":[{"name":"Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas. 3"},{"name":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9315-8583","authenticated-orcid":false,"given":"Nicolette","family":"Mardik","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0575-5711","authenticated-orcid":false,"given":"Xian","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-4788","authenticated-orcid":false,"given":"Tingting","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-0305","authenticated-orcid":false,"given":"Lana A.","family":"Vornik","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-9471","authenticated-orcid":false,"given":"Michelle I.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4822-6602","authenticated-orcid":false,"given":"Shizuko","family":"Sei","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8354-6209","authenticated-orcid":false,"given":"John","family":"Clifford","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-6473","authenticated-orcid":false,"given":"Holger K.","family":"Eltzschig","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-163X","authenticated-orcid":false,"given":"Powel H.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-0914","authenticated-orcid":false,"given":"Zhongming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-0943","authenticated-orcid":false,"given":"Florencia","family":"McAllister","sequence":"additional","affiliation":[{"name":"Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. 6"},{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 8"},{"name":"Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-106X","authenticated-orcid":false,"given":"Jennifer M.","family":"Bailey-Lundberg","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas. 1"},{"name":"The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas. 2"},{"name":"Department of Pathology, Microbiology and Immunology, The University of Nebraska Medical Center, Omaha, Nebraska. 10"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"2026042015185509500_bib1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0013","article-title":"Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions","volume":"13","author":"Carpenter","year":"2023","journal-title":"Cancer Discov"},{"key":"2026042015185509500_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-024-07359-3","article-title":"3D genomic mapping reveals multifocality of human pancreatic precancers","volume":"629","author":"Braxton","year":"2024","journal-title":"Nature"},{"key":"2026042015185509500_bib3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.pan.2021.03.018","article-title":"Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival","volume":"21","author":"Zhao","year":"2021","journal-title":"Pancreatology"},{"key":"2026042015185509500_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/0008-5472.CAN-22-2553","article-title":"CD73-dependent adenosine signaling through Adora2b drives immunosuppression in ductal pancreatic cancer","volume":"83","author":"Faraoni","year":"2023","journal-title":"Cancer Res"},{"key":"2026042015185509500_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"2026042015185509500_bib6","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res"},{"key":"2026042015185509500_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol Rev"},{"key":"2026042015185509500_bib8","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N Engl J Med"},{"key":"2026042015185509500_bib9","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1053\/j.gastro.2018.11.081","article-title":"Genetics, cell biology, and pathophysiology of pancreatitis","volume":"156","author":"Mayerle","year":"2019","journal-title":"Gastroenterology"},{"key":"2026042015185509500_bib10","doi-asserted-by":"crossref","first-page":"1163585","DOI":"10.3389\/fimmu.2023.1163585","article-title":"The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer","volume":"14","author":"Strickland","year":"2023","journal-title":"Front Immunol"},{"key":"2026042015185509500_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026042015185509500_bib12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.celrep.2017.04.052","article-title":"The presence of interleukin-13 at pancreatic ADM\/PanIN lesions alters macrophage populations and mediates pancreatic tumorigenesis","volume":"19","author":"Liou","year":"2017","journal-title":"Cell Rep"},{"key":"2026042015185509500_bib13","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/cancers13122860","article-title":"Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges","volume":"13","author":"Poh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026042015185509500_bib14","doi-asserted-by":"crossref","first-page":"2320411","DOI":"10.1080\/2162402X.2024.2320411","article-title":"Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma","volume":"13","author":"Pothuri","year":"2024","journal-title":"Oncoimmunology"},{"key":"2026042015185509500_bib15","doi-asserted-by":"crossref","first-page":"e22684","DOI":"10.1096\/fj.202201537R","article-title":"CD73-generated extracellular adenosine promotes resolution of neutrophil-mediated tissue injury and restrains metaplasia in pancreatitis","volume":"37","author":"O\u2019Brien","year":"2023","journal-title":"FASEB J"},{"key":"2026042015185509500_bib16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","article-title":"Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender","volume":"20","author":"Fleming","year":"2023","journal-title":"Nat Methods"},{"key":"2026042015185509500_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2026042015185509500_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res"},{"key":"2026042015185509500_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12688\/f1000research.22139.1","article-title":"scRepertoire: an R-based toolkit for single-cell immune receptor analysis","volume":"9","author":"Borcherding","year":"2020","journal-title":"F1000Res"},{"key":"2026042015185509500_bib20","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2026042015185509500_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"2026042015185509500_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","article-title":"Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions","volume":"25","author":"Hruban","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2026042015185509500_bib23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"2026042015185509500_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2020.02.010","article-title":"Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma","volume":"477","author":"Zhao","year":"2020","journal-title":"Cancer Lett"},{"key":"2026042015185509500_bib25","doi-asserted-by":"crossref","first-page":"e202000935","DOI":"10.26508\/lsa.202000935","article-title":"Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages","volume":"4","author":"Kemp","year":"2021","journal-title":"Life Sci Alliance"},{"key":"2026042015185509500_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"2026042015185509500_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-023-06816-9","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","volume":"625","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"2026042015185509500_bib28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-16-2594","article-title":"eIF5A-PEAK1 signaling regulates YAP1\/TAZ protein expression and pancreatic cancer cell growth","volume":"77","author":"Strnadel","year":"2017","journal-title":"Cancer Res"},{"key":"2026042015185509500_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2022.11.009","article-title":"Single-cell transcriptomic and spatial landscapes of the developing human pancreas","volume":"35","author":"Olaniru","year":"2023","journal-title":"Cell Metab"},{"key":"2026042015185509500_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"key":"2026042015185509500_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mam.2012.05.007","article-title":"The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29","volume":"34","author":"Young","year":"2013","journal-title":"Mol Aspects Med"},{"key":"2026042015185509500_bib32","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","article-title":"Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy","volume":"186","author":"Dolton","year":"2023","journal-title":"Cell"},{"key":"2026042015185509500_bib33","doi-asserted-by":"crossref","first-page":"995027","DOI":"10.3389\/fonc.2022.995027","article-title":"Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma","volume":"12","author":"Faraoni","year":"2022","journal-title":"Front Oncol"},{"key":"2026042015185509500_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-22-0260","article-title":"CD73 inhibits cGAS-STING and cooperates with CD39 to promote pancreatic cancer","volume":"11","author":"Jacoberger-Foissac","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"2026042015185509500_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41374-020-00490-5","article-title":"Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer","volume":"101","author":"Singh","year":"2021","journal-title":"Lab Invest"},{"key":"2026042015185509500_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2013.00085","article-title":"Regulation of inflammation by adenosine","volume":"4","author":"Hask\u00f3","year":"2013","journal-title":"Front Immunol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-24-0200\/3483096\/capr-24-0200.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-24-0200\/3489914\/capr-24-0200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/17\/10\/457\/3502306\/capr-24-0200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/17\/10\/457\/3502306\/capr-24-0200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:19:09Z","timestamp":1776712749000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/17\/10\/457\/748694\/Preventive-Treatment-with-a-CD73-Small-Molecule"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,8,3]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-24-0200","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.27142555","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27142546","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27142558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27142540","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27142552","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.27142549","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.7474513","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]}}}